首页> Transplant immunology> Evolving experience of treating antibody-mediated rejection following lung transplantation.

Evolving experience of treating antibody-mediated rejection following lung transplantation.

导出 LinkOut

翻译打印收藏纠错

第一作者： Shinji,Otani

第一单位： Lung Transplant Service, Department of Allergy, Immunology and Respiratory Medicine, The Alfred Hospital, Melbourne, Australia.

作者： Shinji,Otani ^[1] ; Amanda K,Davis ^[2] ; Linda,Cantwell ^[3] ; Steven,Ivulich ^[4] ; Alan,Pham ^[5] ; Miranda A,Paraskeva ^[1] ; Greg I,Snell ^[1] ; Glen P,Westall ^[6]

作者单位： Lung Transplant Service, Department of Allergy, Immunology and Respiratory Medicine, The Alfred Hospital, Melbourne, Australia. ^[1] Department of Hematology, The Alfred Hospital, Melbourne, Australia. ^[2] National Transplant Services, Australian Red Cross Blood Services, Melbourne, Australia. ^[3] Pharmacy Department, The Alfred Hospital, Melbourne, Australia. ^[4] Department of Anatomical Pathology, The Alfred Hospital, Melbourne, Australia. ^[5] Lung Transplant Service, Department of Allergy, Immunology and Respiratory Medicine, The Alfred Hospital, Melbourne, Australia. Electronic address: G.Westall@alfred.org.au. ^[6]

关键词 Antibody-mediated rejection Bronchiolitis obliterans syndrome Chronic lung allograft syndrome Lung transplantation Plasmapheresis Rituximab